How many insider trades does FilingIQ track for DYAI?

FilingIQ tracks 146 Form 4 insider transactions for DYAI (DYADIC INTERNATIONAL INC), covering filings from Apr 12, 2019 onwards. 3 of those were filed in the last 90 days.

Are DYAI insiders net buyers or net sellers?

Across the full Form 4 history for DYAI, 7 transactions (5%) were open-market purchases and 37 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does DYAI insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is DYAI in?

DYADIC INTERNATIONAL INC (DYAI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $30.04M.

DYAI insider trading

NasdaqCM Healthcare

DYADIC INTERNATIONAL INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

146

Last 90 days

Buys / sells

5% / 25%

Market cap

$30.04M

About DYADIC INTERNATIONAL INC

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and large-scale manufacture of cost-effective enzymes, proteins, metabolites, and other biologic products for life sciences, food and nutrition, and bioindustrial applications. In addition, it develops DYAI-100, a C1-SARS-CoV-2 recombinant protein RBD vaccine candidate and first C1, which is in phase 1 clinical trial to produce protein tested in humans. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; joint development agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Company website: www.dyadic.com

DYAI insider activity at a glance

FilingIQ has scored 146 insider transactions for DYAI since Apr 12, 2019. The most recent filing in our index is dated Jul 24, 2026.

Across the full history, 7 open-market purchases and 37 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on DYAI insider trades is 54.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live DYAI trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,075

UNITED THERAPEUTICS Corp

APLS 272

Apellis Pharmaceuticals, Inc.

NUVL 218

Nuvalent, Inc.

KYMR 203

Kymera Therapeutics, Inc.

GH 191

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for DYAI?: FilingIQ tracks 146 Form 4 insider transactions for DYAI (DYADIC INTERNATIONAL INC), covering filings from Apr 12, 2019 onwards. 3 of those were filed in the last 90 days.
Are DYAI insiders net buyers or net sellers?: Across the full Form 4 history for DYAI, 7 transactions (5%) were open-market purchases and 37 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DYAI insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is DYAI in?: DYADIC INTERNATIONAL INC (DYAI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $30.04M.

Methodology & sources

Every DYAI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.